Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Schulz

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Journal of Biological Chemistry|April 10, 1980
The distribution of the components of the cyclic GMP cycle in retinaS J Berger, G W DeVries, J G Carter, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activityT F Seeger, P A Seymour, A W Schmidt, et al.
Journal of Medicinal Chemistry|August 1, 1990
3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indoleJ E Macor, C A Burkhart, J H Heym, et al.
Journal of Medicinal Chemistry|May 23, 1997
Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonistY L Chen, R S Mansbach, S M Winter, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 1996
CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptorsD W Schulz, R S Mansbach, J Sprouse, et al.
Neuropharmacology|December 13, 2006
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aidH Rollema, L K Chambers, J W Coe, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Journal of Biological Chemistry|April 10, 1980
The distribution of the components of the cyclic GMP cycle in retinaS J Berger, G W DeVries, J G Carter, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activityT F Seeger, P A Seymour, A W Schmidt, et al.
Journal of Medicinal Chemistry|August 1, 1990
3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indoleJ E Macor, C A Burkhart, J H Heym, et al.
Journal of Medicinal Chemistry|May 23, 1997
Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonistY L Chen, R S Mansbach, S M Winter, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 1996
CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptorsD W Schulz, R S Mansbach, J Sprouse, et al.
Neuropharmacology|December 13, 2006
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aidH Rollema, L K Chambers, J W Coe, et al.
Pageof 3